The long-term consequences of antiretroviral therapy: a review.
Boyd
Mark
M
Department of Microbiology and Infectious Diseases, Flinders Medical Centre, South Australia, Australia. mark.boyd@fmc.sa.gov.au
Reiss
Peter
P
D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001851:Bone Diseases, Metabolic / Q000209:etiology; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D039682:HIV-Associated Lipodystrophy Syndrome / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008107:Liver Diseases / Q000209:etiology; D008659:Metabolic Diseases / Q000209:etiology / Q000517:prevention & control; D028361:Mitochondrial Diseases / Q000139:chemically induced / Q000517:prevention & control; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D013997:Time Factors
D044966:Anti-Retroviral Agents; D018894:Reverse Transcriptase Inhibitors